Green Planet Bioengineering Co Ltd
GPLB · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 12.16 | -0.51 | 0.00 | 18.59 |
| FCF Yield | -0.32% | -3.50% | -0.07% | -0.91% |
| EV / EBITDA | -303.94 | -25.76 | 246.05 | 17.68 |
| Quality | ||||
| ROIC | 7.64% | 11.03% | 8.52% | 9.42% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.99 | 0.90 | 1.00 | 1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 17.87% | -31.16% | 1.20% | 2.61% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | -157.90 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |